Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-18-018208
Filing Date
2018-10-11
Accepted
2018-10-11 18:52:29
Documents
1
Period of Report
2018-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2753
  Complete submission text file 0001437749-18-018208.txt   4199
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KEMPHARM, INC. 1170 CELEBRATION BLVD., #103 CELEBRATION FL 34747
Business Address
Clifton R. LaDuane (Reporting) CIK: 0001488774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 181119081